Guillermo Browne, General Manager at MSD Colombia, reveals the strategic importance of the Colombian affiliate, hosting a global data management centre and regional pharmacovigilance operations, while highlighting the company’s commitment to continue advancing the therapeutic value of care and the clinical research landscape in Colombia.
With 70 years of presence in Colombia and as one of the most promising MSD affiliates in the region, what is the significance of the Colombian operations to the company?
"The key to success in the Colombian market is access. Some of our products, such as diabetes related treatments, are included in the public health national plan."
